Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Information sources -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (15)	6/12/2003 7:50:02 AM
From: lexi2004	Respond to of 269

Erik...Wow, now THAT was fast.:) Thanks so much and have a good day. Dori

To: Icebrg who wrote (15)	6/12/2003 4:14:29 PM
From: Icebrg	Respond to of 269

Karolinska Institutet University Library - This Week's Link Every week the Library presents a website of special relevance to the field of medical information retrieval. For a website to be chosen, the content must be up-to-date, well structured, reliable and informative. kib.ki.se

To: Icebrg who wrote (15)	6/14/2003 3:30:03 AM
From: Icebrg	Read Replies (1) \| Respond to of 269

Listing of cancer drugs under development. Another list-maintainer is Hem/Onc Today. They are seeing 371 new drugs under development to fight cancer. No double-counting here for different indications. Somewhat surprising there are some 60 plus drugs listed as being under investigation in phase III trials. That is a very high figure considering what comes out from the FDA-side of the pipeline. A fast look at the listed candidate reveals however that also this list might be inflating the figures. Some drugs are already approved (like Rituxan and Herceptin), but tested in other indications. Others have be all means failed, although they have not yet been officially killed (like Titan's CeaVac). hemonctoday.com